[Silicon Motion Announces Results for the Period Ended March 31, 2018 NEWS RELEASE Financial Highlights 1Q 2018 GAAP 1Q 2018 Non-GAAP Net sales $130.3 million (-4 % Q/Q, +2% Y/Y $130.3 million (-4 % Q/Q, +2% Y/Y Gross margin 48.0% 48.0% Operating margin 19.1% 22.1% Earnings per diluted ADS $0]
[TABLE OF CONTENTS Page PART I - 2 - Item 1. Identity of Directors, Senior Management and Advisers - 2 - Item 2. Offer Statistics and Expected Timetable - 2 - Item 3. Key Information - 2 - Item 4. Information on the Company - 17 - Item 4A. Unresolved Staff Comments - 43 - Item 5. Operating and Financ]
[Page Certain Terms and Conventions 1 5 Part I Item 1 Identity of Directors, Senior Management and Advisors 7 Item 2 Offer Statistics and Expected Timetable 7 Item 3 Key Information 7] [CHINA NATIONAL PETROLEUM CORPORATION AND PETROCHINA COMPANY LIMITED COMPREHENSIVE PRODUCTS AND SERVICES AGREE]
[TAL Education Group Announces Unaudited Financial Results for the Fourth Fiscal Quarter and the Fiscal Year 2018 - Quarterly Results: Net Revenues up by 59.4% Year-Over-Year Income from Operations up by 54.0% Year-Over-Year Non-GAAP Income from Operations up by 47.7% Year-Over-Year Total Student Enr]
[Sinovac to Delay Filing of 2017 Annual Report on Form 20-F Following Actions Taken by the Minority Shareholder of Sinovac Beijing BEIJING, April 27, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today ]
[IRANNOTICE 1 a18-12310_1irannotice.htm IRANNOTICE]
[] [1. Hanwha SolarOne Investment Holding Ltd. (BVI) 2. Hanwha Q CELLS Corp. (Korea) 3. 4. Hanwha Q CELLS Hong Kong Limited (PRC) 5. Hanwha Q CELLS (Nantong) Co., Ltd. (PRC) 6. Hanwha Q CELLS Canada Corp. (Canada) 7. Hanwha Q CELLS (Qidong) Co., Ltd. (PRC) 8. Hanwha Q CELLS (Shanghai) Co., Ltd. (PRC)]
[] [EXECUTION VERSION YIXIN CAPITAL LIMITED SERIES C PREFERENCE SHARES SUBSCRIPTION AGREEMENT Dated as of May 11, 2017 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND TERMS 2 Section 1.1 Definitions 2 Section 1.2 Other Definitional Provisions 9 ARTICLE II PURCHASE AND SALE 10 Section 2.1 Sale and Is]
[PART I 3 Item 1. Identity of Directors, Senior Management and Advisers 3 Item 2. Offer Statistics and Expected Timetable 3 Item 3. Key Information 3 Item 4. Information on the Company 27 Item 4A. Unresolved Staff Comments 52 Item 5. Operating and Financial Review and Prospects 52 Item 6. Directors, ]
